| Product Code: ETC4746552 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antimalarial Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antimalarial Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antimalarial Drugs Market - Industry Life Cycle |
3.4 Israel Antimalarial Drugs Market - Porter's Five Forces |
3.5 Israel Antimalarial Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Antimalarial Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Antimalarial Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in the prevalence of malaria cases in Israel |
4.2.2 Government initiatives to combat malaria and promote the use of antimalarial drugs |
4.2.3 Technological advancements in antimalarial drug development |
4.2.4 Growing awareness among healthcare professionals and patients about the importance of antimalarial treatment |
4.3 Market Restraints |
4.3.1 High costs associated with antimalarial drugs |
4.3.2 Limited access to healthcare in certain regions of Israel |
4.3.3 Potential side effects and resistance development to antimalarial drugs |
4.3.4 Regulatory challenges in drug approval and distribution |
5 Israel Antimalarial Drugs Market Trends |
6 Israel Antimalarial Drugs Market Segmentations |
6.1 Israel Antimalarial Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Antimalarial Drugs Market Revenues & Volume, By Quinine, 2021-2031F |
6.1.3 Israel Antimalarial Drugs Market Revenues & Volume, By Chloroquine, 2021-2031F |
6.1.4 Israel Antimalarial Drugs Market Revenues & Volume, By Proguanil, 2021-2031F |
6.1.5 Israel Antimalarial Drugs Market Revenues & Volume, By Mefloquine, 2021-2031F |
6.1.6 Israel Antimalarial Drugs Market Revenues & Volume, By Pyrimethamine, 2021-2031F |
6.1.7 Israel Antimalarial Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Israel Antimalarial Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Antimalarial Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.3 Israel Antimalarial Drugs Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.2.4 Israel Antimalarial Drugs Market Revenues & Volume, By E-Commerce & Other Distribution Channel, 2021-2031F |
7 Israel Antimalarial Drugs Market Import-Export Trade Statistics |
7.1 Israel Antimalarial Drugs Market Export to Major Countries |
7.2 Israel Antimalarial Drugs Market Imports from Major Countries |
8 Israel Antimalarial Drugs Market Key Performance Indicators |
8.1 Number of reported malaria cases in Israel |
8.2 Percentage of population covered by government-funded antimalarial drug programs |
8.3 Research and development investment in new antimalarial drug technologies |
8.4 Adherence rate to antimalarial drug treatment protocols |
8.5 Availability and accessibility of antimalarial drugs in healthcare facilities |
9 Israel Antimalarial Drugs Market - Opportunity Assessment |
9.1 Israel Antimalarial Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Antimalarial Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Antimalarial Drugs Market - Competitive Landscape |
10.1 Israel Antimalarial Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Antimalarial Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here